Cargando…
Long-Term Outcomes with Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia Patients
OBJECTIVE: Tyrosine kinase inhibitor (TKI) is the standard treatment for chronic myeloid leukemia (CML). In the national list of essential medicines in Thailand, the first, second, and third-line treatments are imatinib, nilotinib, and dasatinib, sequentially, different from the European Leukemia Ne...
Autores principales: | Towachiraporn, Saikhuan, Punnachet, Teerachat, Hantrakun, Nonthakorn, Piriyakhuntorn, Pokpong, Rattanathammethee, Thanawat, Hantrakool, Sasinee, Chai-Adisaksopha, Chatree, Rattarittamrong, Ekarat, Norasetthada, Lalita, Tantiworawit, Adisak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495903/ https://www.ncbi.nlm.nih.gov/pubmed/37247270 http://dx.doi.org/10.31557/APJCP.2023.24.5.1513 |
Ejemplares similares
-
D-index and invasive fungal infections (IFIs) in adult acute myeloid leukemia (AML) patients with the first episode of febrile neutropenia
por: Rattanathammethee, Thanawat, et al.
Publicado: (2023) -
Efficacy of ESHAP versus ICE plus dexamethasone (DICE) as salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
por: Boonlerd, Pattamaporn, et al.
Publicado: (2023) -
Impact of antiphospholipid antibodies on thrombotic events in ambulatory cancer patients
por: Kansuttiviwat, Chalermkiat, et al.
Publicado: (2023) -
Psychometric Properties of MD Anderson Symptoms Inventory for Acute Myeloid Leukemia Patients in Thailand
por: Rattanathammethee, Thanawat, et al.
Publicado: (2022) -
Longitudinal Profiles of Anti-Platelet Factor 4 Antibodies in Thai People Who Received ChAdOx1 nCoV-19 Vaccination
por: Hantrakun, Nonthakorn, et al.
Publicado: (2023)